Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 11 of 11 entries
Sorted by: Best Match Show Resources per page
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

The Lancet. Oncology

Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH.
PMID: 34895479
Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 09.

BACKGROUND: Children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after treatment with vincristine, etoposide, prednisone, and doxorubicin (OEPA) followed by cyclophosphamide, vincristine, prednisone, and procarbazine (COPP) and...

Cite
Mauz-Körholz C, Landman-Parker J, Balwierz W, et al. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2021;23(1):125-137doi: 10.1016/S1470-2045(21)00470-8.
Mauz-Körholz, C., Landman-Parker, J., Balwierz, W., Ammann, R. A., Anderson, R. A., Attarbaschi, A., Bartelt, J. M., Beishuizen, A., Boudjemaa, S., Cepelova, M., Claviez, A., Daw, S., Dieckmann, K., Fernández-Teijeiro, A., Fosså, A., Gattenlöhner, S., Georgi, T., Hjalgrim, L. L., Hraskova, A., Karlén, J., Kluge, R., Kurch, L., Leblanc, T., Mann, G., Montravers, F., Pears, J., Pelz, T., Rajić, V., Ramsay, A. D., Stoevesandt, D., Uyttebroeck, A., Vordermark, D., Körholz, D., Hasenclever, D., & Wallace, W. H. (2022). Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. The Lancet. Oncology, 23(1), 125-137. https://doi.org/10.1016/S1470-2045(21)00470-8
Mauz-Körholz, Christine, et al. "Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial." The Lancet. Oncology vol. 23,1 (2022): 125-137. doi: https://doi.org/10.1016/S1470-2045(21)00470-8
Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 09. PMID: 34895479.
Copy Download .nbib Format: NLM
A new vector system for targeted integration and overexpression of genes in the crop pathogen .

Fungal biology and biotechnology

Nielsen MR, Holzwarth AKR, Brew E, Chrapkova N, Kaniki SEK, Kastaniegaard K, Sørensen T, Westphal KR, Wimmer R, Sondergaard TE, Sørensen JL.
PMID: 31890232
Fungal Biol Biotechnol. 2019 Dec 11;6:25. doi: 10.1186/s40694-019-0089-2. eCollection 2019.

No abstract available.

Cite
Nielsen MR, Holzwarth AKR, Brew E, et al. A new vector system for targeted integration and overexpression of genes in the crop pathogen . Fungal Biol Biotechnol. 2019;6:25doi: 10.1186/s40694-019-0089-2.
Nielsen, M. R., Holzwarth, A. K. R., Brew, E., Chrapkova, N., Kaniki, S. E. K., Kastaniegaard, K., Sørensen, T., Westphal, K. R., Wimmer, R., Sondergaard, T. E., & Sørensen, J. L. (2019). A new vector system for targeted integration and overexpression of genes in the crop pathogen . Fungal biology and biotechnology, 625. https://doi.org/10.1186/s40694-019-0089-2
Nielsen, Mikkel Rank, et al. "A new vector system for targeted integration and overexpression of genes in the crop pathogen ." Fungal biology and biotechnology vol. 6 (2019): 25. doi: https://doi.org/10.1186/s40694-019-0089-2
Nielsen MR, Holzwarth AKR, Brew E, Chrapkova N, Kaniki SEK, Kastaniegaard K, Sørensen T, Westphal KR, Wimmer R, Sondergaard TE, Sørensen JL. A new vector system for targeted integration and overexpression of genes in the crop pathogen . Fungal Biol Biotechnol. 2019 Dec 11;6:25. doi: 10.1186/s40694-019-0089-2. eCollection 2019. PMID: 31890232; PMCID: PMC6905090.
Copy Download .nbib Format: NLM
Orellanine specifically targets renal clear cell carcinoma.

Oncotarget

Buvall L, Hedman H, Khramova A, Najar D, Bergwall L, Ebefors K, Sihlbom C, Lundstam S, Herrmann A, Wallentin H, Roos E, Nilsson UA, Johansson M, Törnell J, Haraldsson B, Nyström J.
PMID: 29207627
Oncotarget. 2017 Jul 25;8(53):91085-91098. doi: 10.18632/oncotarget.19555. eCollection 2017 Oct 31.

Renal cell carcinoma (RCC), arising from the proximal tubule in the kidney, accounts for approximately 85% of kidney cancers and causes over 140,000 annual deaths worldwide. In the last decade, several new therapies have been identified for treatment of...

Cite
Buvall L, Hedman H, Khramova A, et al. Orellanine specifically targets renal clear cell carcinoma. Oncotarget. 2017;8(53):91085-91098doi: 10.18632/oncotarget.19555.
Buvall, L., Hedman, H., Khramova, A., Najar, D., Bergwall, L., Ebefors, K., Sihlbom, C., Lundstam, S., Herrmann, A., Wallentin, H., Roos, E., Nilsson, U. A., Johansson, M., Törnell, J., Haraldsson, B., & Nyström, J. (2017). Orellanine specifically targets renal clear cell carcinoma. Oncotarget, 8(53), 91085-91098. https://doi.org/10.18632/oncotarget.19555
Buvall, Lisa, et al. "Orellanine specifically targets renal clear cell carcinoma." Oncotarget vol. 8,53 (2017): 91085-91098. doi: https://doi.org/10.18632/oncotarget.19555
Buvall L, Hedman H, Khramova A, Najar D, Bergwall L, Ebefors K, Sihlbom C, Lundstam S, Herrmann A, Wallentin H, Roos E, Nilsson UA, Johansson M, Törnell J, Haraldsson B, Nyström J. Orellanine specifically targets renal clear cell carcinoma. Oncotarget. 2017 Jul 25;8(53):91085-91098. doi: 10.18632/oncotarget.19555. eCollection 2017 Oct 31. PMID: 29207627; PMCID: PMC5710908.
Copy Download .nbib Format: NLM
Efficacy of photodynamic therapy in women with HSIL, LSIL and early stage squamous cervical cancer: a systematic review and meta-analysis.

Photodiagnosis and photodynamic therapy

Unanyan A, Pivazyan L, Davydova J, Murvatova K, Khrapkova A, Movsisyan R, Ishchenko A, Ishchenko A.
PMID: 34534688
Photodiagnosis Photodyn Ther. 2021 Dec;36:102530. doi: 10.1016/j.pdpdt.2021.102530. Epub 2021 Sep 14.

BACKGROUND: We sought to conduct a systematic review and meta-analysis of randomized and non-randomized clinical trials to assess the efficacy of photodynamic therapy (PDT) in cervical epithelial neoplasia (CIN) and early-stage cervical cancer. Additionally, according to the results, we...

Cite
Unanyan A, Pivazyan L, Davydova J, et al. Efficacy of photodynamic therapy in women with HSIL, LSIL and early stage squamous cervical cancer: a systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2021;36:102530doi: 10.1016/j.pdpdt.2021.102530.
Unanyan, A., Pivazyan, L., Davydova, J., Murvatova, K., Khrapkova, A., Movsisyan, R., Ishchenko, A., & Ishchenko, A. (2021). Efficacy of photodynamic therapy in women with HSIL, LSIL and early stage squamous cervical cancer: a systematic review and meta-analysis. Photodiagnosis and photodynamic therapy, 36102530. https://doi.org/10.1016/j.pdpdt.2021.102530
Unanyan, Ara, et al. "Efficacy of photodynamic therapy in women with HSIL, LSIL and early stage squamous cervical cancer: a systematic review and meta-analysis." Photodiagnosis and photodynamic therapy vol. 36 (2021): 102530. doi: https://doi.org/10.1016/j.pdpdt.2021.102530
Unanyan A, Pivazyan L, Davydova J, Murvatova K, Khrapkova A, Movsisyan R, Ishchenko A, Ishchenko A. Efficacy of photodynamic therapy in women with HSIL, LSIL and early stage squamous cervical cancer: a systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2021 Dec;36:102530. doi: 10.1016/j.pdpdt.2021.102530. Epub 2021 Sep 14. PMID: 34534688.
Copy Download .nbib Format: NLM
Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Berbenyuk A, Bobkova P, Bordyugov S, Borisenko A, Bugaiskaya E, Druzhkova O, Eliseev D, El-Taravi Y, Gorbova N, Gribaleva E, Grigoryan R, Ibragimova S, Kabieva K, Khitrina N, Khrapkova A, Kogut N, Kovygina K, Kvaratskheliya M, Lobova M, Lunicheva A, Maystrenko A, Nikolaeva D, Pavlenko A, Perekosova O, Romanova O, Sokova O, Solovieva V, Spasskaya O, Spiridonova E, Sukhodolskaya O, Suleimanov S, Urmantaeva N, Usalka O, Zaikina M, Zorina A.
PMID: 34173648
Clin Infect Dis. 2021 Jul 01;73(1):174. doi: 10.1093/cid/ciab077.

No abstract available.

Cite
Berbenyuk A, Bobkova P, Bordyugov S, et al. Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection. Clin Infect Dis. 2021;73(1):174doi: 10.1093/cid/ciab077.
Berbenyuk, A., Bobkova, P., Bordyugov, S., Borisenko, A., Bugaiskaya, E., Druzhkova, O., Eliseev, D., El-Taravi, Y., Gorbova, N., Gribaleva, E., Grigoryan, R., Ibragimova, S., Kabieva, K., Khitrina, N., Khrapkova, A., Kogut, N., Kovygina, K., Kvaratskheliya, M., Lobova, M., Lunicheva, A., Maystrenko, A., Nikolaeva, D., Pavlenko, A., Perekosova, O., Romanova, O., Sokova, O., Solovieva, V., Spasskaya, O., Spiridonova, E., Sukhodolskaya, O., Suleimanov, S., Urmantaeva, N., Usalka, O., Zaikina, M., & Zorina, A. (2021). Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(1), 174. https://doi.org/10.1093/cid/ciab077
Berbenyuk, Anna, et al. "Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,1 (2021): 174. doi: https://doi.org/10.1093/cid/ciab077
Berbenyuk A, Bobkova P, Bordyugov S, Borisenko A, Bugaiskaya E, Druzhkova O, Eliseev D, El-Taravi Y, Gorbova N, Gribaleva E, Grigoryan R, Ibragimova S, Kabieva K, Khitrina N, Khrapkova A, Kogut N, Kovygina K, Kvaratskheliya M, Lobova M, Lunicheva A, Maystrenko A, Nikolaeva D, Pavlenko A, Perekosova O, Romanova O, Sokova O, Solovieva V, Spasskaya O, Spiridonova E, Sukhodolskaya O, Suleimanov S, Urmantaeva N, Usalka O, Zaikina M, Zorina A. Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection. Clin Infect Dis. 2021 Jul 01;73(1):174. doi: 10.1093/cid/ciab077. PMID: 34173648; PMCID: PMC8477902.
Copy Download .nbib Format: NLM
Sensing of Surface and Bulk Refractive Index Using Magnetophotonic Crystal with Hybrid Magneto-Optical Response.

Sensors (Basel, Switzerland)

Ignatyeva D, Kapralov P, Golovko P, Shilina P, Khramova A, Sekatskii S, Nur-E-Alam M, Alameh K, Vasiliev M, Kalish A, Belotelov V.
PMID: 33799799
Sensors (Basel). 2021 Mar 11;21(6). doi: 10.3390/s21061984.

We propose an all-dielectric magneto-photonic crystal with a hybrid magneto-optical response that allows for the simultaneous measurements of the surface and bulk refractive index of the analyzed substance. The approach is based on two different spectral features of the...

Cite
Ignatyeva D, Kapralov P, Golovko P, et al. Sensing of Surface and Bulk Refractive Index Using Magnetophotonic Crystal with Hybrid Magneto-Optical Response. Sensors (Basel). 2021;21(6)doi: 10.3390/s21061984.
Ignatyeva, D., Kapralov, P., Golovko, P., Shilina, P., Khramova, A., Sekatskii, S., Nur-E-Alam, M., Alameh, K., Vasiliev, M., Kalish, A., & Belotelov, V. (2021). Sensing of Surface and Bulk Refractive Index Using Magnetophotonic Crystal with Hybrid Magneto-Optical Response. Sensors (Basel, Switzerland), 21(6), . https://doi.org/10.3390/s21061984
Ignatyeva, Daria, et al. "Sensing of Surface and Bulk Refractive Index Using Magnetophotonic Crystal with Hybrid Magneto-Optical Response." Sensors (Basel, Switzerland) vol. 21,6 (2021). doi: https://doi.org/10.3390/s21061984
Ignatyeva D, Kapralov P, Golovko P, Shilina P, Khramova A, Sekatskii S, Nur-E-Alam M, Alameh K, Vasiliev M, Kalish A, Belotelov V. Sensing of Surface and Bulk Refractive Index Using Magnetophotonic Crystal with Hybrid Magneto-Optical Response. Sensors (Basel). 2021 Mar 11;21(6). doi: 10.3390/s21061984. PMID: 33799799; PMCID: PMC8000496.
Copy Download .nbib Format: NLM
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

The Lancet. Oncology

Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH.
PMID: 34895479
Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 09.

BACKGROUND: Children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after treatment with vincristine, etoposide, prednisone, and doxorubicin (OEPA) followed by cyclophosphamide, vincristine, prednisone, and procarbazine (COPP) and...

Cite
Mauz-Körholz C, Landman-Parker J, Balwierz W, et al. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2021;23(1):125-137doi: 10.1016/S1470-2045(21)00470-8.
Mauz-Körholz, C., Landman-Parker, J., Balwierz, W., Ammann, R. A., Anderson, R. A., Attarbaschi, A., Bartelt, J. M., Beishuizen, A., Boudjemaa, S., Cepelova, M., Claviez, A., Daw, S., Dieckmann, K., Fernández-Teijeiro, A., Fosså, A., Gattenlöhner, S., Georgi, T., Hjalgrim, L. L., Hraskova, A., Karlén, J., Kluge, R., Kurch, L., Leblanc, T., Mann, G., Montravers, F., Pears, J., Pelz, T., Rajić, V., Ramsay, A. D., Stoevesandt, D., Uyttebroeck, A., Vordermark, D., Körholz, D., Hasenclever, D., & Wallace, W. H. (2022). Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. The Lancet. Oncology, 23(1), 125-137. https://doi.org/10.1016/S1470-2045(21)00470-8
Mauz-Körholz, Christine, et al. "Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial." The Lancet. Oncology vol. 23,1 (2022): 125-137. doi: https://doi.org/10.1016/S1470-2045(21)00470-8
Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 09. PMID: 34895479.
Copy Download .nbib Format: NLM
Microwave non-contact imaging of subcutaneous human body tissues.

Healthcare technology letters

Kletsov A, Chernokalov A, Khripkov A, Cho J, Druchinin S.
PMID: 26609415
Healthc Technol Lett. 2015 Aug 27;2(5):108-11. doi: 10.1049/htl.2015.0003. eCollection 2015 Oct.

A small-size microwave sensor is developed for non-contact imaging of a human body structure in 2D, enabling fitness and health monitoring using mobile devices. A method for human body tissue structure imaging is developed and experimentally validated. Subcutaneous fat...

Cite
Kletsov A, Chernokalov A, Khripkov A, et al. Microwave non-contact imaging of subcutaneous human body tissues. Healthc Technol Lett. 2015;2(5):108-11doi: 10.1049/htl.2015.0003.
Kletsov, A., Chernokalov, A., Khripkov, A., Cho, J., & Druchinin, S. (2015). Microwave non-contact imaging of subcutaneous human body tissues. Healthcare technology letters, 2(5), 108-11. https://doi.org/10.1049/htl.2015.0003
Kletsov, Andrey, et al. "Microwave non-contact imaging of subcutaneous human body tissues." Healthcare technology letters vol. 2,5 (2015): 108-11. doi: https://doi.org/10.1049/htl.2015.0003
Kletsov A, Chernokalov A, Khripkov A, Cho J, Druchinin S. Microwave non-contact imaging of subcutaneous human body tissues. Healthc Technol Lett. 2015 Aug 27;2(5):108-11. doi: 10.1049/htl.2015.0003. eCollection 2015 Oct. PMID: 26609415; PMCID: PMC4625829.
Copy Download .nbib Format: NLM
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

The Lancet. Oncology

Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH.
PMID: 34895479
Lancet Oncol. 2021 Dec 09; doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 09.

BACKGROUND: Children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after treatment with vincristine, etoposide, prednisone, and doxorubicin (OEPA) followed by cyclophosphamide, vincristine, prednisone, and procarbazine (COPP) and...

Cite
Mauz-Körholz C, Landman-Parker J, Balwierz W, et al. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2021;doi: 10.1016/S1470-2045(21)00470-8.
Mauz-Körholz, C., Landman-Parker, J., Balwierz, W., Ammann, R. A., Anderson, R. A., Attarbaschi, A., Bartelt, J. M., Beishuizen, A., Boudjemaa, S., Cepelova, M., Claviez, A., Daw, S., Dieckmann, K., Fernández-Teijeiro, A., Fosså, A., Gattenlöhner, S., Georgi, T., Hjalgrim, L. L., Hraskova, A., Karlén, J., Kluge, R., Kurch, L., Leblanc, T., Mann, G., Montravers, F., Pears, J., Pelz, T., Rajić, V., Ramsay, A. D., Stoevesandt, D., Uyttebroeck, A., Vordermark, D., Körholz, D., Hasenclever, D., & Wallace, W. H. (2021). Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. The Lancet. Oncology, . https://doi.org/10.1016/S1470-2045(21)00470-8
Mauz-Körholz, Christine, et al. "Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial." The Lancet. Oncology vol. (2021). doi: https://doi.org/10.1016/S1470-2045(21)00470-8
Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2021 Dec 09; doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 09. PMID: 34895479.
Copy Download .nbib Format: NLM
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

The Lancet. Oncology

Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH.
PMID: 34895479
Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 09.

BACKGROUND: Children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after treatment with vincristine, etoposide, prednisone, and doxorubicin (OEPA) followed by cyclophosphamide, vincristine, prednisone, and procarbazine (COPP) and...

Cite
Mauz-Körholz C, Landman-Parker J, Balwierz W, et al. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2021;23(1):125-137doi: 10.1016/S1470-2045(21)00470-8.
Mauz-Körholz, C., Landman-Parker, J., Balwierz, W., Ammann, R. A., Anderson, R. A., Attarbaschi, A., Bartelt, J. M., Beishuizen, A., Boudjemaa, S., Cepelova, M., Claviez, A., Daw, S., Dieckmann, K., Fernández-Teijeiro, A., Fosså, A., Gattenlöhner, S., Georgi, T., Hjalgrim, L. L., Hraskova, A., Karlén, J., Kluge, R., Kurch, L., Leblanc, T., Mann, G., Montravers, F., Pears, J., Pelz, T., Rajić, V., Ramsay, A. D., Stoevesandt, D., Uyttebroeck, A., Vordermark, D., Körholz, D., Hasenclever, D., & Wallace, W. H. (2022). Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. The Lancet. Oncology, 23(1), 125-137. https://doi.org/10.1016/S1470-2045(21)00470-8
Mauz-Körholz, Christine, et al. "Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial." The Lancet. Oncology vol. 23,1 (2022): 125-137. doi: https://doi.org/10.1016/S1470-2045(21)00470-8
Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Lancet Oncol. 2022 Jan;23(1):125-137. doi: 10.1016/S1470-2045(21)00470-8. Epub 2021 Dec 09. PMID: 34895479; PMCID: PMC8716340.
Copy Download .nbib Format: NLM
Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema.

Journal of ophthalmology

Krizova L, Kalousova M, Kubena AA, Chrapek O, Chrapkova B, Sin M, Zima T.
PMID: 26682064
J Ophthalmol. 2015;2015:478509. doi: 10.1155/2015/478509. Epub 2015 Nov 17.

Purpose. We investigated two factors linked to diabetic macular edema (DME), vitreous and serum levels of vascular endothelial growth factor (VEGF) and uric acid (UA) in patients with DME, and compared the results with changes in optical coherence tomography...

Cite
Krizova L, Kalousova M, Kubena AA, et al. Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema. J Ophthalmol. 2015;2015:478509doi: 10.1155/2015/478509.
Krizova, L., Kalousova, M., Kubena, A. A., Chrapek, O., Chrapkova, B., Sin, M., & Zima, T. (2015). Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema. Journal of ophthalmology, 2015478509. https://doi.org/10.1155/2015/478509
Krizova, Libuse, et al. "Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema." Journal of ophthalmology vol. 2015 (2015): 478509. doi: https://doi.org/10.1155/2015/478509
Krizova L, Kalousova M, Kubena AA, Chrapek O, Chrapkova B, Sin M, Zima T. Correlation of Vitreous Vascular Endothelial Growth Factor and Uric Acid Concentration Using Optical Coherence Tomography in Diabetic Macular Edema. J Ophthalmol. 2015;2015:478509. doi: 10.1155/2015/478509. Epub 2015 Nov 17. PMID: 26682064; PMCID: PMC4664812.
Copy Download .nbib Format: NLM
Showing 1 to 11 of 11 entries